HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jacek Suzin Selected Research

nucleolar organizer region associated proteins

2/2014The AgNORs count in predicting long-term survival in serous ovarian cancer.
10/2004[Assessment of the AgNORs count in serous ovarian cancer].
9/2003[Assessment of the influence of chemotherapy on the nucleolar organizer regions (AgNORs) count in serous ovarian cancer cells].
1/2003AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jacek Suzin Research Topics

Disease

13Neoplasms (Cancer)
09/2014 - 04/2002
4Endometrial Neoplasms (Endometrial Cancer)
09/2014 - 05/2012
4Ovarian Neoplasms (Ovarian Cancer)
02/2014 - 01/2003
3Endometriosis
01/2018 - 07/2012
3Endometrial Hyperplasia
09/2014 - 06/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2005 - 07/2004
2Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2004 - 08/2003
1Pain (Aches)
01/2018
1Carcinosarcoma
07/2015
1Carcinogenesis
09/2014
1Endometrioid Carcinoma
10/2013
1Urinary Incontinence
10/2010
1Stress Urinary Incontinence
10/2010
1Atrophy
10/2010
1Overactive Urinary Bladder (Overactive Bladder)
10/2010
1Birth Weight (Birth Weights)
12/2004
1Fetal Weight
12/2004
1Hemorrhage
07/2004
1Myoma
07/2004
1Uterine Hemorrhage (Uterine Bleeding)
09/2003
1Precancerous Conditions
09/2003
1Vulvar Diseases
09/2003
1Vulvar Neoplasms (Vulvar Cancer)
09/2003
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
01/2003
1Infertility (Sterility)
01/2000

Drug/Important Bio-Agent (IBA)

4nucleolar organizer region associated proteinsIBA
02/2014 - 01/2003
3Estrogen ReceptorsIBA
07/2015 - 05/2012
3Estrogens (Estrogen)FDA Link
07/2015 - 10/2010
2ParaffinIBA
02/2014 - 02/2013
2SilverIBA
02/2014 - 02/2013
2Biomarkers (Surrogate Marker)IBA
02/2013 - 07/2012
2Progesterone Receptors (Progesterone Receptor)IBA
02/2013 - 05/2012
2Arginine (L-Arginine)FDA Link
12/2004 - 08/2003
1Danazol (Azol)FDA LinkGeneric
01/2018
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2018
1DesminIBA
07/2015
1Cyclin EIBA
09/2014
1Messenger RNA (mRNA)IBA
06/2014
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2013
1Ki-67 Antigen (Ki 67 Antigen)IBA
06/2013
1ProgesteroneFDA LinkGeneric
02/2013
1Indicators and Reagents (Reagents)IBA
07/2012
1AntigensIBA
07/2012
1Cholinergic Antagonists (Anticholinergics)IBA
10/2010
1Norethindrone Acetate (Norlutate)FDA LinkGeneric
06/2007
1Estradiol (Delestrogen)FDA LinkGeneric
06/2007
1MelatoninIBA
08/2005
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2003
1AcidsIBA
09/2003
1Photosensitizing Agents (Photosensitizers)IBA
09/2003
1NitritesIBA
08/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2003
1TESIBA
01/2000

Therapy/Procedure

4Therapeutics
01/2018 - 09/2003
3Operative Surgical Procedures
10/2004 - 01/2003
3Drug Therapy (Chemotherapy)
09/2003 - 01/2003
2Hysterectomy
07/2004 - 01/2003
2Laparotomy
01/2003 - 04/2002
1Minimally Invasive Surgical Procedures
01/2018
1Conservative Treatment
01/2018
1Pessaries
10/2010
1Ligation
07/2004
1Photochemotherapy (Photodynamic Therapy)
09/2003
1Adjuvant Chemotherapy
01/2003